Interestingly, CYP1A1 has been implicated in polyunsaturated fatty acid metabolism,17 and CYP1A1 polymorphisms have been associated with chronic kidney disease of unknown aetiology.18 Likewise, the other members of the CEBPB pathway have a relevance in endothelial function. This evidence concerns the gene CEBPB and chronic kidney disease.